1 |
Phumisantiphong U, Siripanichgon K, Reamtong O, Diraphat P. 2017. A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci. PLOS ONE 12:e0186415.
|
2 |
Raquib M, Borpuzari T, Choudhary RK, Rahman H. 2003. Isolation and characterization of Lactobacilli isolated from market sample of sour dahi. Indian Vet J 80:791-794.
|
3 |
Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. 2016. Biomedical applications of nisin. J Appl Microbiol 120:1449-1465.
DOI
|
4 |
Yoon SH. 2020. Application of bacteriocin-producing lactic acid bacteria in fresh cheese for efficient control of Listeria monocytogenes. M.S. thesis, Chung-Ang Univ., Anseong, Korea.
|
5 |
de Noordhout CM, Devleesschauwer B, Angulo FJ, Verbeke G, Haagsma J, Kirk M, Havelaar A, Speybroeck N. 2014. The global burden of listeriosis: A systematic review and meta-analysis. Lancet Infect Dis 14:1073-1082.
DOI
|
6 |
Garde S, Gaya P, Medina M, Nunez M. 1997. Acceleration of flavour formation in cheese by a bacteriocin-producing adjunct lactic culture. Biotechnol Lett 19:1011-1014.
DOI
|
7 |
Lungu B, Ricke SC, Johnson MG. 2009. Growth, survival, proliferation and pathogenesis of Listeria monocytogenes under low oxygen or anaerobic conditions: A review. Anaerobe 15:7-17.
DOI
|
8 |
Kim OS, Cho YJ, Lee K, Yoon SH, Kim M, Na H, Park SC, Jeon YS, Lee JH, Yi H, Won S, Chun J. 2012. Introducing EzTaxon-e: A prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol 62:716-721.
DOI
|
9 |
Kondrotiene K, Kasnauskyte N, Serniene L, Golz G, Alter T, Kaskoniene V, Maruska AS, Malakauskas M. 2018. Characterization and application of newly isolated nisin producing Lactococcus lactis strains for control of Listeria monocytogenes growth in fresh cheese. LWT-Food Sci Technol 87:507-514.
DOI
|
10 |
Li Q, Montalban-Lopez M, Kuipers OP. 2018. Increasing the antimicrobial activity of nisin-based lantibiotics against Gramnegative pathogens. Appl Environ Microbiol 84:e00052-18.
|
11 |
Melo J, Andrew PW, Faleiro ML. 2015. Listeria monocytogenes in cheese and the dairy environment remains a food safety challenge: The role of stress responses. Food Res Int 67:75-90.
DOI
|
12 |
Mills S, Serrano LM, Griffin C, O'Connor PM, Schaad G, Bruining C, Hill C, Ross RP, Meijer WC. 2011. Inhibitory activity of Lactobacillus plantarum LMG P-26358 against Listeria innocua when used as an adjunct starter in the manufacture of cheese. Microb Cell Fact 10:S7.
|
13 |
Munoz A, Ananou S, Galvez A, Martinez-Bueno M, Rodriguez A, Maqueda M, Valdivia E. 2007. Inhibition of Staphylococcus aureus in dairy products by enterocin AS-48 produced in situ and ex situ: Bactericidal synergism with heat. Int Dairy J 17:760-769.
DOI
|
14 |
Dal Bello B, Cocolin L, Zeppa G, Field D, Cotter PD, Hill C. 2012. Technological characterization of bacteriocin producing Lactococcus lactis strains employed to control Listeria monocytogenes in cottage cheese. Int J Food Microbiol 153:58-65.
DOI
|
15 |
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410.
DOI
|
16 |
Arques JL, Rodriguez E, Nunez M, Medina M. 2011. Combined effect of reuterin and lactic acid bacteria bacteriocins on the inactivation of food-borne pathogens in milk. Food Control 22:457-461.
DOI
|
17 |
Avila M, Garde S, Medina M, Nunez M. 2005. Effect of milk inoculation with bacteriocin-producing lactic acid bacteria on a Lactobacillus helveticus adjunct cheese culture. J Food Prot 68:1026-1033.
DOI
|
18 |
Ayad EHE, Nashat S, El-Sadek N, Metwaly H, El-Soda M. 2004. Selection of wild lactic acid bacteria isolated from traditional Egyptian dairy products according to production and technological criteria. Food Microbiol 21:715-725.
DOI
|
19 |
Coelho MC, Silva CCG, Ribeiro SC, Dapkevicius MLNE, Rosa HJD. 2014. Control of Listeria monocytogenes in fresh cheese using protective lactic acid bacteria. Int J Food Microbiol 191:53-59.
DOI
|
20 |
Cook DP, Gysemans C, Mathieu C. 2018. Lactococcus lactis as a versatile vehicle for tolerogenic immunotherapy. Front Immunol 8:1961.
|